Recently, studies on the rs266729 polymorphism have found that CC allele carriers have low serum ANP concentrations[6], and GG gene carriers are more likely to suffer from metabolic syndrome and insulin resistance [3, 7], both of which are risk factors for AD onset. This evidence concerns the gene NPPA and metabolic syndrome.